contrast, dementia patients have a dramatically decreased number of dependent symptoms and signs. In those with severe dementia, dependence between symptoms and signs virtually disappears; the cognitive degeneration is paralleled by breakdown of interdependence of the symptoms and signs. These 26 symptoms and signs were ultimately reduced to ten from which we derived a diagnostic algorithm which identified 87.3% of the dementia cases diagnosed by the clinicians (4) . The algorithm identified 83.5% of all clinical diagnoses of Alzheimer's disease and 77.7% of vascular dementia (4) .
We restricted our analysis for this report to the 1132 cases diagnosed with dementia. To arrive at more specific characterizations of these diagnostic categories, probable Alzheimer's disease (AD) and vascular dementia (VaD) were analysed by severity. Four types of possible AD (with atypical presentation, with vascular component, with parkinsonism, with coexisting illness possibly contributing to dementia) were treated as distinct entities to further investigate their unique characteristics.
Analysis
Calculation of probabilities for the diagnosis. Let p(D i | X j ) be the proportion of the group of patients with symptom X j who also have diagnosis D i (i.e., the conditional probability of D i given X j ), where i=1,...,N, N is the number of diagnostic groups, and j=1,...,M, M is the number of binary symptoms and signs. In other words, p(D i | X j ) is a posterior probability of the diagnosis D i , given symptom X j. For a given subject, each sign may be present (X j =1), or absent (X j =0). Let us introduce ð(D i | X j ) = p(D i | X j ) if X j =1, and ð(D i | X j ) = 1-p(D i |X j ), if X j =0. Let p(X j | D i ) be the probability of the occurrence of sign X j , given the i-th diagnosis.
According to Bayes formula, we can write the probability of the diagnosis D i , given symptom X j :
where p(D i ) is a prior probability of the i-th diagnosis. The probability of the diagnosis D i , given all the signs (present or absent) is ð(D i |X 1 ,...,X N ). In the case of statistical independence between symptoms and signs, this probability may be expressed as a product of the probabilities of D i given each sign:
Bayes formula represents posterior probabilities as a combination of prior probabilities with the weights depending on the occurrence of signs among all the diagnoses. We demonstrated previously that as cognitive neurodegeneration progresses, synergies (statistically significant conditional dependencies) between the signs dramatically weaken and disappear altogether in severe dementia (26) . Therefore, we applied the assumption of independence of signs to simplify the formula (2) . The formula may be written as follows:
From the database, the estimates of prior probability p(D i ) are the proportion of people in diagnostic group D i to the total number of dementia cases (n=1132); ð(X j | D i ) are estimated as the proportion of people in diagnostic group D i who have the j-th symptom (if X j =1) or do not have the j-th symptom (X j =0). 
At the level of significance p < 0.01, the correlation coefficient may be significantly distinguished from zero, if r > 0.069. At the more rigorous level of significance (p < 0.001), r > 0.0915.
RESULTS

Vector diagnostics
Diagnostic vectors were calculated for all individuals with dementia using Bayes' formula, equation (2) . As expected, there was a nonuniform distribution among all eleven diagnoses. As a rule, one or two diagnoses dominated, displaying comparatively larger probabilities than the others. In Table 1 we present three individual cases as examples of the vector diagnoses. Patient 1 had impairment in abstract thinking, judgement, memory, independent activities of daily living (IADLs) and mood disturbances, resulting in a physician diagnosis of moderate probable Alzheimer's disease. Patient 2 was diagnosed by a study physician with moderate vascular dementia showing evidence of the following symptoms and signs: arterial hypertension, episodes of agitation, aphasia, stroke history, memory impairment, mood disturbances, ADL and IADL impairment. Patient 3 had a diagnosis of severe vascular dementia with symptoms and signs of arterial hypertension, history of stroke, focal signs, impairment in muscle bulk, agnosia, aphasia and apraxia, memory, abstract thinking and judgement, posture, muscle strength, limb tone, gait abnormalities, ADL and IADL impairment.
As illustrated in Table 1 , the dominant Bayesian diagnosis for Patient 1 is moderate probable Alzheimer's disease (p=0.6305), with a secondary probability of mild probable AD (p=0.2709). This corresponds well with the study physician diagnosis of moderate probable Alzheimer's disease. In Patient 2 however, the Bayesian diagnoses are more ambiguous. We can see that although this patient received a study diagnosis of moderate vascular dementia, this ranked third among the Bayesian diagnoses. In order of probability, the Bayesian diagnoses for this patient are moderate probable Alzheimer's disease (p=0.3679) and possible Alzheimer's disease with vascular components (p=0.3507) predominate, followed by moderate vascular dementia (p=0.1264) and possible Alzheimer's with coexisting morbidity (p=0.1179). An ideal situation is represented in the case of Patient 3, where the physician's diagnosis of severe vascular dementia is strongly corroborated by the Bayesian diagnosis (p=0.98).
Comorbidity diagnostics
Bayesian vector diagnostics provides us with a list of probabilities for all potential diagnoses for each individual case. In the examples we provide here, information on 26 symptoms and signs is used to derive a Bayesian diagnosis for each patient. Table 1 illustrates this using three cases. Alternatively, when we turn our attention to interpretation of the population data (i.e. all 1132 cases), we can calculate the correlation matrix between the probabilities for all diagnoses (Table 2 ). In the ideal scenario, assuming an independent, categorical disease state typically excluding any other diagnosis, we would see high negative correlation coefficient values for each pair of diagnoses (in an ideal scenario, correlations would equal -1). However, if comorbidity occurs, we would expect to see non-significant negative, or even positive correlation coefficients between diagnoses.
In Table 2 one can see that the values of r are negative for almost all the diagnoses. A negative significant correlation coefficient value characterizes a reciprocal relationship between the two respective diagnoses, that is, the presence of one diagnosis seldom co-occurs with the other. Because of our large sample size, we were able to choose a strict level of significance for the correlation coefficient (p<.001) which ensures significance at |r|$ 0.0915. However, some of the diagnoses show insignificant negative or, indeed, significantly positive correlations. This means that these diagnostic categories can not be distinguished (i.e., they are not strictly independent). Thus, diagnoses of possible AD with atypical presentation have not been reliably distinguished from mild probable AD (r=0.4439) or moderate probable AD (r=0.2238) within the data collection protocol. Similarly, diagnoses of possible AD with vascular components and moderate vascular dementia might be blurred (r=0.2779). Similarly, possible AD with Parkinsonism and Parkinson's dementia are not easily distinguishable (r=0.2696), as well as possible AD with coexisting morbidity and moderate probable AD (r=0.3937).
It can also be seen that there is no strongly evident distinction between mild and moderate vascular dementia (r=0.3088). Similarly, the distinction between mild and moderate probable AD is also weak (r=-0.0456). Therefore we conclude that, at least in the situation examined here using the 26 considered symptoms and signs, there is statistical support for diagnostic ambiguity by the physicians in using the mild and moderate levels of severity of probable Alzheimer's disease and vascular dementia.
DISCUSSION
This paper introduces the concept of vector diagnostics. In contrast to the conventional approach where one diagnosis takes precedence, we propose an alternative strategy which addresses the clinical reality of individuals for whom dementia co-morbidities occur. In this way, the diagnosis for an individual becomes a multidimensional object. Conventional diagnoses may be considered as coordinates with lists of the diagnostic system considered as frames of reference for vector diagnostics. Probabilities for each diagnosis determine the projection of the vector diagnosis in the direction towards this diagnosis. The probability distribution is computed according to Bayes' theorem.
A question may be raised as to how the results of vector diagnostics correspond to conventional diagnostics. Keeping in mind that if each clinical diagnostic system is independent (i.e. that each diagnosis contradicts all other diagnoses), we expect a negative correlation coefficient between the probabilities of alternate diagnoses. We therefore calculated these correlations, derived from the Bayesian algorithm. The significance of the values of these correlation coefficients is based upon the value of p. If we chose, for example, p < 0.01, the correlation coefficient *r* is significant at the level greater than 0.069. Similarly, for p < 0.001, *r* > 0.0915. Table 2 illustrates that at the level p < 0.01, 39 correlation coefficients are significantly negative from the total of 55 correlation coefficients. At a more rigorous level, p < 0.001, 35 coefficients remain significantly negative. However, the number of significantly positive correlations does not change if the p value varies from 0.001 to 0.01. Positive correlations indicate comorbidity of the respected diagnoses. Thus, variation of the significance level does not affect our main results and the construct of como rbidity is reflected in the data.
As currently presented, this report has two chief limitations. The first is the validity of our choice of the 26 symptoms and signs used to inform the differential diagnosis. As detailed elsewhere (4), these were chosen on the basis of their content validity (as determined by an expert clinical panel) and their discriminative ability, determined empirically (as an aspect of construct validity). It is nevertheless the case that the choice of other symptoms or signs may alter the probabilities which we report. On first principles, we favour a method of choosing symptoms and signs which does not rely exclusively on either expert judgement or uninformed empiricism. Inevitably, our choice is determined by the items in the database, but our rationale for the approach is rooted in the need to use existing datasets to advance our understanding of the diagnostic process. The alternative is that such databases become obsolete every time new diagnostic entities are described.
A second limitation concerns the possible relationship between symptoms and signs in the database. The central restriction in the application of the Bayesian approach is associated with the structure of dependencies between different descriptors. Since this structure is usually unknown, the decomposition of Bayes' formula (equations 1 to 3) is, generally speaking, questionable. Addressing this concern, we have demonstrated previously that as cognitive degeneration progresses, the coordination (dependency) between symptoms and signs in an individual weaken (26) . This weakening coincides with increasing independence between the signs. Since this application of Bayes' theorem assumes independence, we might conservatively expect the Bayesian diagnoses to better fit the greater the impairment. While some of the dependencies may remain, although weakened, a certain underestimation of severe cases may occur. Nonetheless, these diagnoses provide us with an approximate estimate by which we can further address the situation we describe of cognitive degeneration. To the extent that the lack of independence of signs makes the diagnosis more problematic in the mildly impaired, the limitation to the application of our approach reflects clinical reality.
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Uncertainty of diagnosis: probabilistic versus deterministic paradigm
In this paper we set out to test our hypothesis that the aetiological causes of the dementia syndrome may sometimes coexist in an individual. We developed a methodology using a Bayesian approach for the analysis of the clinical diagnostic data. This technique establishes a quantifiable measure (correlation coefficient) of the degree of comorbidity.
In analyzing the correspondence between what might be called a vector diagnostics approach and the conventional clinical approach, we demonstrate that some of our diagnostic categories (for example, possible AD with atypical presentation, mild and moderate probable AD) could not be distinguished reliably on the basis of the considered subset of symptoms and signs. In consequence, as noted above, new symptoms might be introduced. Alternatively, the conventional diagnostic approach might require revision, part of the ongoing process in diagnosing dementia.
Recently, Prince applied Bayes' theorem to an approach to establish the most predictive combination of tests for use in the early identification of Alzheimer's disease (18) . In common with Prince, our analysis is limited by the circularity of applying the algorithm on the same population from which it has been derived. However, in contrast, the CSHA data were collected on a population representative sample and therefore allow us to better approximate reliable and generalizable population prevalence estimates. In future, this approach might be used to test any criteria which can be generalized using items in our database. A further test of this approach is to compare our findings with those in an alternate database.
Our proposed approach offers the advantage of accounting for all possible diagnostic states for an individual. This approach may assist the physician in patient-specific appropriate treatment which can depend on not only the primary (most probable) diagnosis, but also on other possible comorbidities. In addition, it allows further exploration of boundary or anomalous cases with atypical presentations not meeting current criteria which might reveal as yet unrecognized disease aetiologies in large epidemiological databases. 
